A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
An Open-Label and Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate
Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Undergoing
Hematopoietic Stem Cell Transplantation to Reduce the Risk of Infection and Graft vs. Host
Disease